Cardiovascular & Hematological Disorders-Drug Targets
Title:EDITORIAL (Thematic Issue: Novel Oral Anticoagulation-A Milestone in Anticoagulation History)
Volume: 15 Issue: 2
Author(s): Mustafa Yildiz and Ibrahim Akin
Affiliation:
Export Options
About this article
Cite this article as:
Yildiz Mustafa and Akin Ibrahim, EDITORIAL (Thematic Issue: Novel Oral Anticoagulation-A Milestone in Anticoagulation History), Cardiovascular & Hematological Disorders-Drug Targets 2015; 15 (2) . https://dx.doi.org/10.2174/1871529X1502151209124012
DOI https://dx.doi.org/10.2174/1871529X1502151209124012 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
Related Journals
Related Books
33
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Treatment Related Morbidity in Cervical Cancer
Current Women`s Health Reviews A Very Rare Cerebral Complication of Chemotherapy in a Young Girl: A Difficult Diagnosis
Current Drug Safety Treatment of PSA only Recurrence of Prostate Cancer After Prior Local Therapy
Current Pharmaceutical Design Thrombolysis in Ischemic Stroke: Focus on New Treatment Strategies
Recent Patents on Cardiovascular Drug Discovery The Interaction Between Gender and Diabetes Mellitus in the Coronary Heart Disease Risk
Current Pharmaceutical Design Current Concepts Underlying Benefits of Exercise Training in Congestive Heart Failure Patients
Current Cardiology Reviews Hyperhomocysteinaemia: A Critical Review of Old and New Aspects
Current Drug Metabolism Safety of New Oral Anticoagulants for Patients with Chronic Kidney Disease
Current Pharmaceutical Design Recent Developments in Antiplatelet Therapy after Percutaneus Coronary Intervention
Cardiovascular & Hematological Disorders-Drug Targets Rheumatoid Arthritis: Genetic Variants as Biomarkers of Cardiovascular Disease
Current Pharmaceutical Design Inflammation-Mediating Proteases: Structure, Function in (Patho) Physiology and Inhibition
Protein & Peptide Letters Human Immunodeficiency Virus (HIV) and Stroke: Targets for Intervention
Infectious Disorders - Drug Targets Pharmacogenetically Tailored Treatments for Heart Disease
Current Pharmaceutical Design Mechanisms And Prevention Of TAVI-Related Cerebrovascular Events
Current Pharmaceutical Design Current Therapeutic Strategies and Future Perspectives for the Treatment of Venous Thromboembolism
Current Pharmaceutical Design Sustained Delivery of Interferons by Micro- and Nanosystems
Recent Patents on Materials Science Invasive and Pharmacological Treatment of Deep Vein Thrombosis: A Scoping Review
Current Pharmaceutical Design Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Assessment of Response to Treatment and Follow-Up in Gastroenteropancreatic Neuroendocrine Neoplasms
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of Estrogen and Estrogen-Related Drugs in Cardiovascular Diseases
Current Drug Metabolism Biologically Responsive Nanosystems Targeting Cardiovascular Diseases
Current Drug Delivery